Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes

Preclinical evaluation of antigen-specific nanotherapy based on phosphatidylserine-liposomes for type 1 diabetes

Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of insulin-producing cells. Due to the ability of apoptotic cells clearance to induce tolerance, we previously generated liposomes rich in phophatidylserine (PS) –a feature of apoptotic cells– loaded with insulin peptides to mi...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Adrian Villalba, Silvia Rodriguez-Fernandez, Rosa-Maria Ampudia, Mary Cano-Sarabia, David Perna-Barrull, Cesc Bertran-Cobo, Clara Ehrenberg, Daniel Maspoch, Marta Vives-Pi
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Taylor & Francis Group 2020-01-01
Seri Bilgileri:Artificial Cells, Nanomedicine, and Biotechnology
Konular:
Nanovesicles
immunotherapy
autoimmunity
Online Erişim:https://www.tandfonline.com/doi/10.1080/21691401.2019.1699812

Internet

https://www.tandfonline.com/doi/10.1080/21691401.2019.1699812

Benzer Materyaller